American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$311M |
| 2 |
Humana
HUM
|
+$270M |
| 3 |
Meta Platforms (Facebook)
META
|
+$256M |
| 4 |
Colgate-Palmolive
CL
|
+$163M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$160M |
Top Sells
| 1 |
Amazon
AMZN
|
+$653M |
| 2 |
Microsoft
MSFT
|
+$614M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$348M |
| 4 |
L3Harris
LHX
|
+$242M |
| 5 |
Idexx Laboratories
IDXX
|
+$238M |
Sector Composition
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Marriott Vacations Worldwide
VAC
$2.66B
| $247K | ﹤0.01% |
1,865
+355
| +24% | +$47.1K |
|
2352
Lincoln Educational Services
LINC
$654M
| $246K | ﹤0.01% |
43,814
-5,549
| -11% | -$31.2K |
|
2353
Kura Oncology
KURA
$713M
| $246K | ﹤0.01% |
20,760
+3,377
| +19% | +$40.1K |
|
2354
Frontline
FRO
$5.34B
| $245K | ﹤0.01% |
15,019
| – | – |
|
2355
Standard Motor Products
SMP
$894M
| $244K | ﹤0.01% |
+6,745
| New | +$244K |
|
|
TWOU
2356
DELISTED
2U, Inc.
TWOU
| $244K | ﹤0.01% |
+1,186
| New | +$244K |
|
2357
J&J Snack Foods
JJSF
$2B
| $239K | ﹤0.01% |
1,633
+245
| +18% | +$35.8K |
|
2358
Freshworks
FRSH
$3.66B
| $239K | ﹤0.01% |
+16,196
| New | +$239K |
|
|
DSKE
2359
DELISTED
Daseke, Inc. Common Stock
DSKE
| $233K | ﹤0.01% |
31,003
+11,402
| +58% | +$85.9K |
|
2360
Clean Energy Fuels
CLNE
$531M
| $232K | ﹤0.01% |
53,264
+8,432
| +19% | +$36.8K |
|
2361
IonQ
IONQ
$17.6B
| $232K | ﹤0.01% |
45,659
+14,779
| +48% | +$75.1K |
|
2362
Workiva
WK
$4.38B
| $230K | ﹤0.01% |
+2,306
| New | +$230K |
|
2363
IDEAYA Biosciences
IDYA
$2.15B
| $230K | ﹤0.01% |
17,023
+5,111
| +43% | +$68.9K |
|
2364
Crawford & Co Class A
CRD.A
$515M
| $229K | ﹤0.01% |
27,515
-5,350
| -16% | -$44.5K |
|
2365
NVE Corp
NVEC
$327M
| $229K | ﹤0.01% |
+2,837
| New | +$229K |
|
|
DCPH
2366
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $229K | ﹤0.01% |
15,215
+3,277
| +27% | +$49.2K |
|
2367
Nature's Sunshine
NATR
$300M
| $228K | ﹤0.01% |
22,304
+675
| +3% | +$6.91K |
|
2368
Theravance Biopharma
TBPH
$725M
| $228K | ﹤0.01% |
21,204
+8,506
| +67% | +$91.3K |
|
|
MRTX
2369
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $227K | ﹤0.01% |
6,199
+286
| +5% | +$10.5K |
|
2370
FuelCell Energy
FCEL
$213M
| $227K | ﹤0.01% |
2,726
+204
| +8% | +$17K |
|
2371
CNA Financial
CNA
$12.6B
| $227K | ﹤0.01% |
5,824
+1,069
| +22% | +$41.7K |
|
2372
Clearway Energy Class A
CWEN.A
$3.21B
| $227K | ﹤0.01% |
7,650
-1,500
| -16% | -$44.5K |
|
2373
Veracyte
VCYT
$2.51B
| $227K | ﹤0.01% |
10,994
+1,286
| +13% | +$26.5K |
|
|
HSKA
2374
DELISTED
Heska Corp
HSKA
| $226K | ﹤0.01% |
+2,326
| New | +$226K |
|
2375
Resources Connection
RGP
$175M
| $226K | ﹤0.01% |
13,419
+2,781
| +26% | +$46.9K |
|